Captopril Inhibits Tumor Growth in Kidney Cancer
Author Information
Author(s): S-I Hii, DL Nicol, DC Gotley, LC Thompson, MK Green, JR Jonsson
Primary Institution: University of Queensland, Princess Alexandra Hospital
Hypothesis
Does captopril reduce tumor growth in a model of human renal cell carcinoma?
Conclusion
Captopril significantly reduces tumor growth in a mouse model of human renal cell carcinoma.
Supporting Evidence
- Captopril treatment resulted in a significant reduction in tumor size compared to untreated mice.
- The weight of tumor-bearing kidneys in treated mice was significantly lower than in controls.
- Captopril did not significantly affect the proliferation of RCC cells in vitro at clinically achievable concentrations.
Takeaway
Captopril, a blood pressure medication, helps shrink kidney tumors in mice, but it doesn't seem to directly stop the cancer cells from growing.
Methodology
The study used SCID mice inoculated with human RCC cells and treated them with captopril to assess tumor growth.
Limitations
The study was conducted in mice, and further research is needed to understand the mechanism of captopril's effects.
Participant Demographics
Male severe combined immunodeficient (SCID) mice, 8 weeks old at the start of the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website